List view / Grid view

Dr Emma Murphy (Alzheimer’s Research UK Oxford Drug Discovery Institute)



Assay design for Alzheimer’s disease: key considerations and emerging trends

26 April 2024 | By

In this Q&A, we speak to Dr Emma Murphy, Head of Biology at the Alzheimer’s Research UK Oxford Drug Discovery Institute. Among her many insights, she discusses how the challenges in developing reproducible assays can be addressed, as well as strategies used to translate promising findings into clinically relevant tools…